A Long Term Follow up Study of Patients Who Have Completed the PEP005-020 Study
NCT00952783
·
clinicaltrials.gov ↗
COMPLETED
Status
98
Enrollment
INDUSTRY
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
Lesion count
Sponsor
Peplin